Choroidal Vascularity Index as a Biomarker for Visual Response to Antivascular Endothelial Growth Factor Treatment in Diabetic Macular Edema

Table 3

Multifactor regression analysis for detecting the prognostic factors of the response to the antivascular endothelial growth factor (VEGF) treatment by a generalized estimating equation model with adjusting for correlation between two eyes within the same patient ( eyes).

	OR (95% CI)
Age	1.01 (0.97, 1.07)	0.658
BCVA	1.00 (0.97, 1.04)	0.840
Stage of DR	1.04 (0.41, 2.63)	0.942
CVI	0.17 (0.05, 0.61)	0.006
Adjusted reflectivity of EZ	0.56 (0.36, 0.86)	0.007
DRIL	6.71 (2.26, 19.89)	0.001
SRF	0.29 (0.12, 0.73)	0.008

OR: odds ratio; CI: confidence interval; BCVA: best-corrected visual acuity; CVI: choroidal vascularity index; EZ: ellipsoid zone; DRIL: disorganization of the retinal inner layers; SRF: subretinal fluid.